Stock Research for ACHN

ACHN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ACHN Stock Chart & Research Data

The ACHN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACHN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ACHN Due diligence Resources & Stock Charts

The ACHN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACHN Detailed Price Forecast - CNN Money CNN View ACHN Detailed Summary - Google Finance
Yahoo View ACHN Detailed Summary - Yahoo! Finance Zacks View ACHN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ACHN Trends & Analysis - Trade-Ideas Barrons View ACHN Major Holders - Barrons
NASDAQ View ACHN Call Transcripts - NASDAQ Seeking View ACHN Breaking News & Analysis - Seeking Alpha
Spotlight View ACHN Annual Report - CompanySpotlight.com OTC Report View ACHN OTC Short Report - OTCShortReport.com
TradeKing View ACHN Fundamentals - TradeKing Charts View ACHN SEC Filings - Bar Chart
WSJ View Historical Prices for ACHN - The WSJ Morningstar View Performance/Total Return for ACHN - Morningstar
MarketWatch View the Analyst Estimates for ACHN - MarketWatch CNBC View the Earnings History for ACHN - CNBC
StockMarketWatch View the ACHN Earnings - StockMarketWatch MacroAxis View ACHN Buy or Sell Recommendations - MacroAxis
Bullish View the ACHN Bullish Patterns - American Bulls Short Pains View ACHN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ACHN Stock Mentions - StockTwits PennyStocks View ACHN Stock Mentions - PennyStockTweets
Twitter View ACHN Stock Mentions - Twitter Invest Hub View ACHN Investment Forum News - Investor Hub
Yahoo View ACHN Stock Mentions - Yahoo! Message Board Seeking Alpha View ACHN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ACHN - SECform4.com Insider Cow View Insider Transactions for ACHN - Insider Cow
CNBC View ACHN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACHN - OTC Markets
Yahoo View Insider Transactions for ACHN - Yahoo! Finance NASDAQ View Institutional Holdings for ACHN - NASDAQ


Stock Charts

FinViz View ACHN Stock Insight & Charts - FinViz.com StockCharts View ACHN Investment Charts - StockCharts.com
BarChart View ACHN Stock Overview & Charts - BarChart Trading View View ACHN User Generated Charts - Trading View




Latest Financial News for ACHN


Should You Buy Achillion Pharmaceuticals, Inc. (ACHN)?
Posted on Tuesday December 11, 2018

Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter. NASDAQ and Russell 2000 indices are already in correction territory. More importantly, Russell 2000 ETF (IWM) underperformed the larger S&P 500 ETF (SPY) by about 4 percentage points in the first half of […]


Achillion Interim Clinical Trial Data and Strategic Update Planned for Dec 17th, 2018
Posted on Monday December 10, 2018

Achillion Pharmaceuticals, Inc. (ACHN), a clinical-stage biopharmaceutical company focused on advancing its orally administered factor D complement inhibitors into late-stage development and commercialization, announced today that the company will host a live webcast and conference call on December 17th at 4:30PM EST. Joseph Truitt, President and Chief Executive Officer and Dr. Stephen Zelenkofske, Executive Vice President and Chief Medical Officer will present Achillion’s 2019 development plans along with interim data for the Company’s Phase 2 clinical trials in PNH and C3G as well as initial Phase 1 data on Achillion’s next generation factor D inhibitors.


RA Capital Was Wrong about Achillion Pharmaceuticals, Inc. (ACHN): Is it Time To Buy?
Posted on Saturday December 08, 2018

The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don’t follow. Because of their pay structures, they have strong incentive to do the research necessary […]


Implied Volatility Surging for Achillion (ACHN) Stock Options
Posted on Monday December 03, 2018

Achillion (ACHN) needs investors to pay close attention to the stock based on moves in the options market lately.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.